Email this article 
Hide
Show all
OPEN ACCESS | 
PEER-REVIEWED |
SHORT COMMUNICATION
|
DOWNLOAD PDF
|
VIEW FULL-TEXT PDF
| TOTAL VIEWS
Validated RP-HPLC and HPTLC methods for simultaneous estimation of febuxostat and diclofenac sodium in pharmaceutical dosage form
Ponnuveetil Gopi Sunitha (1)
, Kaliappan Ilango (2,*) (1) Department of Pharmaceutical Chemistry, College of Pharmacy, Madras Medical College, Chennai, 600003, Tamil Nadu, India
(2) Department of Pharmaceutical Chemistry, Sri Ramaswamy Memorial College of Pharmacy, Sri Ramaswamy Memorial University, Kattankulathur, 603203, Tamil Nadu, India
(*) Corresponding Author
Received: 05 Apr 2014 | Revised: 01 May 2014 | Accepted: 01 May 2014 | Published: 30 Sep 2014 | Issue Date: September 2014
Abstract
The present work reports a reverse phase high performance liquid chromatography (RP-HPLC) method and high performance thin layer chromatography (HPTLC) method for the simultaneous determination of febuxostat and diclofenac sodium in pharmaceutical dosage form. HPLC was performed using a Thermo Hypersil C18 column (250 × 4.6 mm i.d., 5 μm particle size) using a mixture of methanol: KH2PO4 (0.02 M) (70:30, v:v) as mobile phase. Ultraviolet detection was carried out at 280 nm. The retention time of febuxostat and diclofenac sodium were found to be 6.725 and 8.892 min, respectively. The HPTLC separation was conducted on Merck HPTLC aluminum sheets of silica gel 60 F254 as stationary phase using toluene:methanol in the ratio of 7:3 (v:v) as the mobile phase. The detection of febuxostat and diclofenac sodium was carried out at 297 nm. The Rf values of febuxostat and diclofenac sodium were found to be 0.48 and 0.60, respectively. Both the methods were validated as per ICH guidelines. The proposed methods were found to be suitable for the quantification of the selected combination of drugs in pharmaceutical dosage form.
Announcements
One of our sponsors will cover the article processing fee for all submissions made between May 17, 2023 and May 31, 2023 (Voucher code: SPONSOR2023).
Editor-in-Chief
European Journal of Chemistry
Keywords
Full Text:
PDF
DOI: 10.5155/eurjchem.5.3.545-549.1066
Links for Article
| | | | | | |
| | | | | | |
| | | |
Related Articles
Article Metrics
This Abstract was viewed 1511 times |
PDF Article downloaded 643 times
Funding information
Centaur Pharmaceuticals Ltd., Pune, India
Citations
[1]. Fawzi A. El-Yazbi, Omayma A. Amin, Eman I. El-Kimary, Essam F. Khamis, Sameh E. Younis
HPTLC and Spectrophotometric Estimation of Febuxostat and Diclofenac Potassium in Their Combined Tablets
Journal of Chromatographic Science 54(7), 1146, 2016
DOI: 10.1093/chromsci/bmw091
[2]. Hassan Rasoulzadeh, Amir Sheikhmohammadi, Navid Alinejad, Mohammad Reza Alipour, Mostafa Hadei, Seyed Mohsen Aghaei Zarch, Rasul Nasiri, Mohsen Saadani
Investigation of behaviours of diclofenac adsorption onto different adsorbents of carbon- aerogel by the kinetic and isotherm non-linear models
International Journal of Environmental Analytical Chemistry , 1, 2023
DOI: 10.1080/03067319.2022.2162390
[3]. Abdel-Maaboud I. Mohamed, Mahmoud A. Omar, Sayed M. Derayea, Mohamed A. Hammad, Abobakr A. Mohamed
Innovative thin-layer chromatographic method combined with fluorescence detection for specific determination of Febuxostat: Application in biological fluids
Talanta 176, 318, 2018
DOI: 10.1016/j.talanta.2017.08.051
[4]. Mahmoud A. Omar, Abdel-Maaboud I. Mohamed, Sayed M. Derayea, Mohamed A. Hammad, Abobakr A. Mohamed
Specific and highly sensitive spectrofluorimetric method for determination of febuxostat in its tablets and real human plasma. Application to stability studies
RSC Advances 6(77), 73432, 2016
DOI: 10.1039/C6RA11246C
[5]. Fawzy A El-Yazbi, Omayma A Amin, Eman I El-Kimary, Essam F Khamis, Sameh E Younis, Mohammed AW Elkhatib, Ahmed F El-Yazbi
A novel HPLC-DAD method for simultaneous determination of febuxostat and diclofenac in biological samples: pharmacokinetic outcomes
Bioanalysis 11(1), 41, 2019
DOI: 10.4155/bio-2018-0219
References
[1]. Sweetman, S. C., Martindale: The Complete Drug Reference, 37th edition, Pharmaceutical Press, London, 2011.
[2]. O'Neil, M. J. The Merck Index, 14th edition, Merck Research Laboratories, 2011.
[3]. Bagga, P.; Salman, M.; Siddiqui, H. H.; Ansari, M. A.; Mehmood, T.; Singh, K. Int. J. Pharm. Sci. Res. 2011, 2(10), 2655-2659.
[4]. Kumar, R. J.; Kumar, B. R.; Patnaik, V. V.; Kumar, A. Int. Res. J. Pharm. 2012, 3(11), 205-208.
[5]. Nasare, M.; Harshini, S.; Kumar, A. M.; Diwan, V.P. Int. J. Pharm. Chem. Biol. Sci. 2012, 3(1), 137-142.
[6]. Sudhir, M. S.; Venkata, N. R.; Nadendla, R. R. Int. J. Pharm. Tech. Res. 2012, 4(4), 974-984.
[7]. Krishnareddy, Y.; Sundaraganapathy, A.; Thangadurai, S. A.; Hemanth, G.; Jambulingam, M.; Niraimathi, V. J. Pharm. Res. 2012, 5(7), 3900-3908.
[8]. Rajyalakshmi, C.; Benjamin, T.; Babu, C. R. Int. J. Res. Pharm. Biomed. Sci. 2013, 4(1), 138-144.
[9]. Patel, S. D.; Sharma, N.; Patel, C. M.; Patel, N. B.; Shrivatsav, S. P.; Sanyal, M. J. Adv. Pharm. Sci. Tech. 2013, 1(1), 37-41.
[10]. Mandle, D. S.; Burade, K. B. Int. J. Pharm. Biol. Res. 2013, 4(1), 1-10.
[11]. Mollati, S.; Rao, V.; Jagaveera, K. N. Am. J. Pharm. Res. 2013, 3(2), 406-422.
[12]. Wang, H.; Deng, P.; Chen, X.; Guo, L.; Zhong, D. Biomed. Chromatogr. 2013, 27(1), 34-38.
http://dx.doi.org/10.1002/bmc.2744
[13]. Prakash, K.; Patro, S. S.; Shanta, K. K.; Rao, M. E. B. Acta Cienc. Indica. 2004, 135, 135-138.
[14]. Ahmed, N. R. Iraqi Nat. J. Chem. 2011, 44, 467-473.
[15]. Mandava, V.; Rao, B.; Reddy, B. C. K.; Rao, T. S.; Prasanthi, V. Rasayan J. Chem. 2009, 2, 488-490.
[16]. Barry, A.; Mahmood, M.; Hamezh, J. M. J. Kerbala Univ. 2009, 7, 310-316.
[17]. Akshaya, A. K.; Joshi, G. K.; Mishra, P. Ind. J. Pharm. Sci. 1992, 54, 44-46.
[18]. Baria, H. S.; Patil, P.; Modi, H.; Patel, P.; Patel, S.; Chandalia, K. Inv. Rap. Pharm. Anal. Qual. Ass. 2013, 3, 627-631.
[19]. Mothalia, C. P.; Prajapati, K. R.; Parmar, R. R.; Shah, V. N.; Shah, D. A. Int. J. Pharm. Sci. 2013, 4(3), 268-278
[20]. Priya, M. H. Int. J. Pharm. Bio. Sci. 2013, 4(3), 134-138.
[21]. ICH Q2 (R1), Validation of Analytical Procedures: Text and Methodology, The International Federation of Pharmaceutical Manufacturers & Associations, Geneva, Switzerland, 2005.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.5.3.545-549.1066
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
Save to Zotero
Save to Mendeley
European Journal of Chemistry 2014, 5(3), 545-549 | doi: https://doi.org/10.5155/eurjchem.5.3.545-549.1066 | Get rights and content
Refbacks
- There are currently no refbacks.
Copyright (c)
© Copyright 2010 - 2023 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.